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Vital Brazil Hospital in Butantan Institute, Sao Paulo, Brazil
Snake bites are very common in many rural areas of
frica, Asia and Latin America. The victims, in general,
re young adult males bitten during agricultural activities.
nake bites envenoming is one of the major neglected dis-
ases of the 21st century. The data about the morbidity and
ortality are limited but it’s estimated, globally, at least
21,000 envenoming and 20,000 deaths each year and also
hat almost 1.2 million to 5.5 million snake bites could occur
nnually. The snakes related with the most severe cases of
nake bite envenoming belong to Elapidae (cobras, kraits,
ambas, Australasian species and sea snakes) and Viperi-
ae (rattlesnakes, lance-headed pit vipers and true vipers)
amilies. The families Atractaspididae and Colubridae are
esponsible for a small fraction of the snake bites with med-
cal importance in Africa, Middle East and Central Asia. The
enus Echis sp. (saw-scaled vipers) in northern Africa, Naja
p. (cobras) and Bungarus sp. (kraits) in Asia and Bothrops
p. in Latin America are responsible for signiﬁcant numbers
f severe cases and deaths. The snake venoms are a com-
lex mixture of many families of toxins as haemorrhagins,
eurotoxins, serinoproteases, phospolipases, myotoxins and
thers. The most frequent emergencies in snake bites are
aused or a consequence a result of clotting and bleed-
ng disturbances, rhabdomyolisis, intravascular haemolysis,
uscle paralysis, local and systemic acute inﬂammation and
onsequent complications like severe hemorrhage, acute
enal failure, acute respiratory failure, hypotension and
hock, septicemia and severe local complications as com-
artmental syndrome, necrosis and amputation. The correct
uantity of speciﬁc antivenom by the intravenous route, as
oon as possible and supportive treatment are essential. The
ain challenges to control snake bites accidents are the pro-
uction and large distribution of high quality antivenoms and
xtensive and systematic training of the health care workers
bout diagnosis and treatment of snake bites.
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he Discovery of HIV
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Soon after, the ﬁrst report of AIDS in the United States in
981, similar cases were observed in France. In December
982, a working group of clinicians contacted retrovirolo-
ists at the Institut Pasteur to work on the hypothesis that a
etrovirus might be the cause of AIDS. Together, they deﬁne
successful strategy to isolate HIV from a patient at risk of
IDS. This discovery was the start of a collective adventure,
hich mobilized clinicians, multidisciplinary researchers
nd patients, altogether. Such a networking turned out to be
ery efﬁcient for providing scientiﬁc evidences and for trans-
ating them rapidly into diagnosis, prevention and treatment
f HIV infection. Since these early days, we have learnt that
IV infection is much more complex than initially thought.
e have gained signiﬁcant insights into the HIV biology
nd pathogenesis. Early virologic and immunologic events,
articularly at mucosal sites, including the early virus dis-
emination, the establishment of viral reservoirs and the
ery rapid immune dysfunctions are critical in both HIV
cquisition and/or disease progression.
Despite all the enormous progress made during the last 27
ears at international level, HIV/AIDS epidemic still there.
esearch priorities still remain care, treatment and preven-
ion. One of the major scientiﬁc challenges is to develop
n efﬁcient HIV/AIDS vaccine. Conventional immunization
trategies may not be sufﬁcient to elicit protection. We
learly need to elucidate the precise mechanisms that are
overning the induction of protective immunity against HIV,
aking into consideration the most recent advances in innate
mmunity and insights on early innate effectors that HIV
an alter, including at mucosal sites. Lessons learned from
istinct models of protection in human and non-human pri-
ates and new approaches, including systems biology will
ertainly contribute to novel concepts for future HIV vaccine
esearch and development.
oi:10.1016/j.ijid.2010.02.1502
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Inducible Dormant (ID) MRSA are mecA gene-positive
.aureus isolates that change from initial MSSA phenotype
o CA-MRSA phenotype after !-lactam antibiotic exposure
They can be identiﬁed by SCC mec type. ID-MRSA has been
eported in both hospital and community settings.
